Launch Event – 6 th November 2014 Trial Information and Design Isabel Rubie – Trial Manager The NAtional Trial of Tonsillectomy IN Adults: a clinical and.

Slides:



Advertisements
Similar presentations
The CAREDEM feasibility study Joint CIs: Iliffe (UCL) & Robinson (Newcastle University) PIs: Robinson (North east), Livingston (London), Fox (Kent)
Advertisements

Safety Reporting IN Clinical Trials
ADVERSE EVENT REPORTING
A feasibility study to explore patient, clinician and GP decision making of acute recurrent tonsillitis for NATTINA: The NAtional Trial of Tonsillectomy.
Pharmacy flu service Presented by Kate Birkenhead Public Health Commissioning Manager NHS England September 2014.
? This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 06/301/233) and.
Elements of a clinical trial research protocol
Capturing and Reporting Adverse Events in Clinical Research
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes …in an academic collaboration with.
How do nurses use new technologies to inform decision making?
Trial Procedures and Forms
Background Commissioned call NIHR HTA Objective: To determine if invasive ventilation using protocolised weaning that includes non- invasive ventilation.
SPIRIT 2 Initiation: June Contents Key Facts Study Summary Patient recruitment –Inclusion criteria –Consent Forms –Randomisation –Study Schedule.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Overview of the hospital’s computer systems
Requirements of EU pharmacovigilance legislation for distributors Julia Sipos Quality Management Director Pharmacovigilance coordinator Version 03.
Liverpool Care Pathway in Nursing Homes Pat Mowatt Education Facilitator for Palliative Care for the Nursing Homes.
Template for study specific training for Intrapartum Research Studies [ Please see guide before using this]
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
1 MRC SUPREMO (BIG 2-04) Selective Use of Postoperative Radiotherapy aftEr MastectOmy Phase III randomised trial of chest wall RT in intermediate- risk.
Mobile Phone Technology and Male Circumcision Programs Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Arusha, Tanzania,
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
S1316 – The Malignant Bowel Obstruction Study Forms and Procedures Katie Arnold, MS SWOG Statistical Center Seattle, WA 10/24/2014S1316 Training1.
Examination of the effects at one year of referral for brief intervention by an Alcohol Health Worker (AHW) on levels of alcohol consumption, psychiatric.
A&E St. Mary’s 'Scientia Vincit Timorem' Alcohol Screening and Brief Intervention Research Programme national brief intervention research consortium Paolo.
The SCIN (Skin care intervention in nurses) Trial: A Cluster Randomised Trial Dr I. Madan (Guy’s & St Thomas’ NHS Foundation Trust), Dr V. Parsons (King’s.
18 Week RTT – MSK Event Judith Park, General Manager for Surgical and Critical Care.
AE/SAE/EAE Identification and Reporting AE/SAE/EAE Identification and Reporting.
COMBS FORD SURGERY Patient Information Screen September 2015.
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
1 Centre for Sport and Exercise Science, Sheffield Hallam University, U. K. 2 York Trials Unit, Department of Health Sciences, University of York, U. K.
The AMBER study Abdominal Massage for Neurogenic Bowel Dysfunction in People with Multiple Sclerosis Background Objective Study Design and AMBER Study.
Agenda Introduction Study Objectives Study Design Delegation
Treatment, outcome and plans for the final phase Dr Barbara A Gregson Trial Director.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) SAR/SUSAR Mette Krag Dept. of Intensive Care 4131 Copenhagen University Hospital Rigshospitalet,
Brittle N 1, Mant J 2, McManus R 1, Lasserson D 3, Sackley C 1 Are TIAs as transient as the name suggests?
Does vertebral artery stenting prevent recurrent stroke in symptomatic vertebral artery stenosis? September 2015 TitleName Trial Office Number Trial.
Site Initiation Presentation **site **date PRISM SIV Version /04/2016 Prevention of Respiratory Insufficiency after Surgical Management: PRISM trial.
Audit of Day Case Tonsillectomy Aintree University Hospital, Liverpool M Baghat 1, S Knott 2, G Bessant 2, EZ Osman 2. 1:Faculty of Medicine, Alexandria.
A Randomised Controlled Trial of standard care wound management versus negative pressure wound therapy in the treatment of adult patients with an open.
Randomised Evaluation of Surgery with Craniectomy for patients Undergoing Evacuation of Acute Subdural Haematoma Contact: Arti Gulati Interim RESCUE-ASDH.
Jeopardy Game - Sample This is an example of a jeopardy game that could be used during data collection training. This is an example of a jeopardy game.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Post-It Notes to Improve Questionnaire Response Rates in RCTs Findings from a Randomised Sub-Study Ada Keding 1, Helen Lewis 2, Kate Bosanquet 2, Simon.
Medical Needs Coordinator Sam Bartram Attendance and Exclusions (Education Inclusion Service) Statutory role (as defined by statutory guidance for LAs)
Area Agency on Aging of Central Texas H. Richard McGhee, AAA Director Thomas Wilson, AAA VD-HCBS Consultant Jim Reed, CTCOG Executive Director.
SPIRIT 2 Initiation: prepared November Key Facts UK Multicentre study (NCRN adopted) Looking for 810 patients from UK Current status First patient.
MTN-025/HOPE Decliner Population Procedures. Who are the Decliner Population? Former ASPIRE participants who decline or express no interest in joining.
The Southampton Mobility Volunteer programme to increase physical activity levels of older inpatients: a feasibility study (SoMoVe) Dr Stephen Lim Specialist.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Bedford House Medical Centre Thinking of Going Abroad?
admissions in residents in care homes.
A real life example of intervention retention and follow up in the community: problem solving for self-harm in prisons.
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
REPORTING ADVERSE EVENTS AND COMPLETING THE REPORT FORM
Safety Reporting V6.0 17/01/17.
MAINTAINING THE INVESTIGATOR’S SITE FILE
Clinicaltrials.gov Update
The DEPression in Visual Impairment Trial:
STudying Acute exaceRbations and Response: The COPD STARR 2 study
Feasibility Study) PB-PG
Amanda Lilley-Kelly Senior Trial Co-ordinator
Consultant Respiratory Physician Professor of Primary Care Oncology
Dr Kerry Woolfall Kerry_woolfall
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
Jessica Wood, Graeme MacLennan & Jemma Hudson
THE UK MINI MITRAL TRIAL
MAINTAINING THE INVESTIGATOR’S STUDY FILE
WHAT TO DO IF A PATIENT DEVELOPS AN UNEXPECTED PROBLEM?
Dr Tim England TICH-2 SAE adjudicator
Presentation transcript:

Launch Event – 6 th November 2014 Trial Information and Design Isabel Rubie – Trial Manager The NAtional Trial of Tonsillectomy IN Adults: a clinical and cost effectiveness study

Trial Management Newcastle Clinical Trials Unit Institute of Health and Society

Phases 1)Feasibility Study 2)Internal Pilot 3)Main Trial

Feasibility Summary Feasibility study recruitment 1 st July 2014 – 30 th November 2014 Qualitative & Cognitive Interviews 15 ENT patients, 20 ENT staff, 10 GPs Multi-centre

Study Summary – NATTINA Multi-centre Randomised controlled surgical trial Tonsillectomy vs conservative management - 1:1 ratio Recruitment target: - Internal Pilot - 72 patients (6 months) - Main Trial patients (18 months)

Sites Aberdeen Glasgow Dundee Newcastle Sunderland York Birmingham Bradford London

Set up: November December 2014 Set up: December January 2015 Internal Pilot recruitment ends 31 st May 2015 Set up: June 2015 Main Trial recruitment ends 31 st December

Primary Objective To compare the effectiveness and efficiency of tonsillectomy versus nonsurgical management for recurrent acute tonsillitis

Objectives 1) Clinical Effectiveness 2) Economic Evaluation 3)Qualitative Process Evaluation 4)Future Research

Inclusion Criteria Age  16 years Recurrent sore throats which fulfil current SIGN guidance for elective tonsillectomy Patient has provided written informed consent for participation in the study prior to any study specific procedures

Exclusion Criteria Under 16 years of age Previous tonsillectomy Listed directly during emergency admission Inability to complete self-reported questionnaires & returns Tonsillectomy required for other indications: Equipoise influenced by other clinical considerations: Primary sleep breathing disorder Suspected malignancy Tonsilloliths Pregnant or breastfeeding Bleeding diathesis Therapeutic anticoagulation

Process Flowchart

Schedule of Events

Screening

All patients who attend an ENT clinic visit having been referred by a GP for recurrent sore throat PIS posted to patients with confirmation of their clinic appointment Activities at screening: Eligibility check Discussion & Information DVD Screening log

Screening Form

Declining Patients Offered: Record reasons for decline on screening log -Comparison Data Form -Qualitative interview with a researcher

Consent & Randomisation

Eligible patients only Consent form must be signed before the baseline questionnaire / randomisation 2) Baseline Questionnaire Pack NCTU online randomisation: Stratified by centre and severity (TOI 14) 4) Participant Contact Details Form 1) Consent 3) Randomisation

Weekly Alerts & STARs

Weekly alerts: No. of sore throat days over previous 7 days SMS / / IVR STAR (Sore Throat Alert Return) When patient experiences a sore throat Requests information on: - Severity - Use of over-the-counter / prescription medications - Healthcare advice sought - No. of hours unable to perform usual daily activities - SF-12

Surgery

‘Immediate Tonsillectomy’ participants only Within 6-8 weeks of randomisation Phone calls at 1 & 2 weeks post surgery

Follow-Up

6 month & 18 month follow up - Follow up questionnaire pack (home) 12 month & 24 month follow up visit - Follow up questionnaire pack (clinic) - Assessment on willingness to remain in deferred surgery group +

Adverse Events Any untoward medical occurrence in a subject to whom a study intervention has been administered AEs to be collected: Events / reactions during surgery or before discharge Events / reactions reported by patient at 1 and 2 week post-surgery follow up telephone calls Recorded in electronic CRF

Serious Adverse Events Any untoward occurrence (expected or not) that: Results in death Is life threatening Requires hospitalisation / prolongation of existing hospitalisation Results in persistent / significant disability / incapacity Trial Manager / CI must be notified within 24 hours of site being made aware SAE reported using SOHO 66: Fax:

GP Linkage Data Aim: To collect primary health care usage data to support weekly returns / STAR data / questionnaires / post-operative follow up calls Collected after 24 month follow up Covers 24 month enrolment + 6 months prior to recruitment Data collection arranged with GP via NCTU / LCRN Data to be collected: - Adverse Events* - Attendance to GP / walk in clinic / A&E* - Hospitalisations / emergency referrals* - Prescriptions issued* - Any additional interventions* *due to sore throat or related event

Questions? Anything not covered today will be covered in more detail at your Site Initiation Visit For further information please contact: Isabel Rubie (Trial Manager) Newcastle Clinical Trials Unit Telephone: Fax: This project was funded by the National Institute for Health Research (NIHR) Heath Technology Assessment (HTA Programme (project number 12/146/06). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA, NIHR, NHS or the Department of Health.